ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
5
views
0
references
Top references
cited by
41
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,018
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
The carrier potential of liposomes in biology and medicine (second of two parts).
Author(s):
G Gregoriadis
Publication date:
1976-09-30
Journal:
The New England journal of medicine
Keywords:
Adjuvants, Immunologic
,
Animals
,
Blood Proteins
,
metabolism
,
Cell Membrane
,
Cells
,
Cells, Cultured
,
Diabetes Mellitus
,
drug therapy
,
Enzymes
,
administration & dosage
,
therapeutic use
,
Humans
,
Liposomes
,
Lysosomes
,
Metabolism, Inborn Errors
,
enzymology
,
Neoplasms
,
Pharmaceutical Preparations
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Resource Identification
Author and article information
Journal
PubMed ID::
785256
DOI::
10.1056/NEJM197609302951406
Keywords:
Adjuvants, Immunologic
,
Animals
,
Blood Proteins
,
metabolism
,
Cell Membrane
,
Cells
,
Cells, Cultured
,
Diabetes Mellitus
,
drug therapy
,
Enzymes
,
administration & dosage
,
therapeutic use
,
Humans
,
Liposomes
,
Lysosomes
,
Metabolism, Inborn Errors
,
enzymology
,
Neoplasms
,
Pharmaceutical Preparations
Data availability:
Keywords:
Adjuvants, Immunologic
,
Animals
,
Blood Proteins
,
metabolism
,
Cell Membrane
,
Cells
,
Cells, Cultured
,
Diabetes Mellitus
,
drug therapy
,
Enzymes
,
administration & dosage
,
therapeutic use
,
Humans
,
Liposomes
,
Lysosomes
,
Metabolism, Inborn Errors
,
enzymology
,
Neoplasms
,
Pharmaceutical Preparations
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,018
Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma [Corrigendum]
Authors:
Selective exposure partly relies on faulty affective forecasts
Authors:
Charles A. Dorison
,
Julia Minson
,
Todd Rogers
Influence of the fluidity of liposome compositions on percutaneous absorption.
Authors:
N Pérez-Cullell
,
L Coderch
,
A de la Maza
…
See all similar
Cited by
40
Nanopharmaceuticals (part 1): products on the market
Authors:
Volkmar Weissig
,
Tracy Pettinger
,
Nicole Murdock
Tumour-targeted nanomedicines: principles and practice
Authors:
T Lammers
,
W. E. Hennink
,
G Storm
Evolution of macromolecular complexity in drug delivery systems
Authors:
Robert S. Langer
,
Ashok Kakkar
,
Giovanni Traverso
…
See all cited by